|
1
|
Xiong S, Peng H, Ding X, Wang X, Wang L,
Wu C, Wang S, Xu H and Liu Y: Circular RNA expression profiling and
the potential role of hsa_circ_0089172 in Hashimoto's thyroiditis
via sponging miR125a-3p. Mol Ther Nucleic Acids. 17:38–48. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu C, Ma J, Liu Y, Tong J, Tian J, Chen
J, Tang X, Xu H, Lu L and Wang S: Increased frequency of follicular
helper T cells in patients with autoimmune thyroid disease. J Clin
Endocrinol Metab. 97:943–950. 2012. View Article : Google Scholar
|
|
3
|
Hahsimoto H: Zur Kenntnis der
lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa).
Arch Klin Chir. 97:219–248. 1912.
|
|
4
|
Takami HE, Miyabe R and Kameyama K:
Hashimoto's thyroiditis. World J Surg. 32:688–692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vanderpump MP, Tunbridge WM, French JM,
Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H,
Tunbridge F, et al: The incidence of thyroid disorders in the
community: A twenty-year follow-up of the whickham survey. Clin
Endocrinol (Oxf). 43:55–68. 1995. View Article : Google Scholar
|
|
6
|
Hollowell JG, Staehling NW, Flanders WD,
Hannon WH, Gunter EW, Spencer CA and Braverman LE: Serum TSH, T(4),
and thyroid antibodies in the United States population (1988 to
1994): National health and nutrition examination survey (NHANES
III). J Clin Endocrinol Metab. 87:489–499. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Penta L, Cofini M, Lanciotti L, Leonardi
A, Principi N and Esposito S: Hashimoto's disease and thyroid
cancer in children: Are they associated? Front Endocrinol
(Lausanne). 9:5652018. View Article : Google Scholar
|
|
8
|
Takasu N and Yoshimura Noh J: Hashimoto's
thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism.
Expert Rev Clin Immunol. 4:221–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng H, Liu Y, Tian J, Ma J, Tang X, Yang
J, Rui K, Zhang Y, Mao C, Lu L, et al: Decreased expression of
microRNA-125a-3p upregulates interleukin-23 receptor in patients
with Hashimoto's thyroiditis. Immunol Res. 62:129–136. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caturegli P, De Remigis A and Rose NR:
Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun
Rev. 13:391–397. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu S and Rayman MP: Multiple nutritional
factors and the risk of Hashimoto's thyroiditis. Thyroid.
27:597–610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu F, Jin L, Jin Y, Nie Z and Zheng H:
Long noncoding RNAs in autoimmune diseases. J Biomed Mater Res A.
107:468–475. 2019. View Article : Google Scholar
|
|
13
|
Tian X, Zheng Y, Yin K, Ma J, Tian J,
Zhang Y, Mao L, Xu H and Wang S: LncRNA AK036396 inhibits
maturation and accelerates immunosuppression of polymorphonuclear
myeloid-derived suppressor cells by enhancing the stability of
ficolin B. Cancer Immunol Res. 8:565–577. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng Y, Tian X, Wang T, Xia X, Cao F,
Tian J, Xu P, Ma J, Xu H and Wang S: Long noncoding RNA Pvt1
regulates the immuno-suppression activity of granulocytic
myeloid-derived suppressor cells in tumor-bearing mice. Mol Cancer.
18:612019. View Article : Google Scholar
|
|
16
|
Zimmer-Bensch G: Emerging roles of long
non-coding rnas as drivers of brain evolution. Cells. 8:13992019.
View Article : Google Scholar
|
|
17
|
Zhang K, Shi ZM, Chang YN, Hu ZM, Qi HX
and Hong W: The ways of action of long non-coding RNAs in cytoplasm
and nucleus. Gene. 547:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Wu S, Zhu X, Zhang L, Deng J, Li
F, Guo B, Zhang S, Wu R, Zhang Z, et al: LncRNA-encoded polypeptide
ASRPS inhibits triple-negative breast cancer angiogenesis. J Exp
Med. 217:jem.201909502020. View Article : Google Scholar :
|
|
19
|
Lorenzen JM and Thum T: Long noncoding
RNAs in kidney and cardiovascular diseases. Nat Rev Nephrol.
12:360–373. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Q, Han CL, Wang KL, Sui YP, Li ZB,
Chen N, Fan SY, Shimabukuro M, Wang F and Meng FG: Integrated
analysis of exosomal lncRNA and mRNA expression profiles reveals
the involvement of lnc-MKRN2-42:1 in the pathogenesis of
Parkinson's disease. CNS Neurosci Ther. 26:527–537. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Atianand MK, Caffrey DR and Fitzgerald KA:
Immunobiology of long noncoding RNAs. Annu Rev Immunol. 35:177–198.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moradi M, Gharesouran J, Ghafouri-Fard S,
Noroozi R, Talebian S, Taheri M and Rezazadeh M: Role of NR3C1 and
GAS5 genes polymorphisms in multiple sclerosis. Int J Neurosci.
130:407–412. 2020. View Article : Google Scholar
|
|
23
|
Moharamoghli M, Hassan-Zadeh V, Dolatshahi
E, Alizadeh Z and Farazmand A: The expression of GAS5, THRIL, and
RMRP lncRNAs is increased in T cells of patients with rheumatoid
arthritis. Clin Rheumatol. 38:3073–3080. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang JB, Li J, Zhang TP, Lv TT, Li LJ, Wu
J, Leng RX, Fan YG, Pan HF and Ye DQ: Expression of several long
noncoding RNAs in peripheral blood mononuclear cells of patients
with systemic lupus erythematosus. Adv Med Sci. 64:430–436. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo J, Liu T and Teng W: LncRNA profile in
Hashimoto's thyroiditis and potential function of NONHSAT079547.2.
J Mol Endocrinol. 64:259–270. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gilbert GL and Kerridge I: The politics
and ethics of hospital infection prevention and control: A
qualitative case study of senior clinicians' perceptions of
professional and cultural factors that influence doctors' attitudes
and practices in a large Australian hospital. BMC Health Serv Res.
19:2122019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu L, Shen P, Zheng B, Yu W, Ji J and
Xiao Y: Comparative genomic analysis of 19 clinical isolates of
tigecycline-resistant acinetobacter baumannii. Front Microbiol.
11:13212020. View Article : Google Scholar :
|
|
28
|
Kechin A, Boyarskikh U, Kel A and
Filipenko M: CutPrimers: A new tool for accurate cutting of primers
from reads of targeted next generation sequencing. J Comput Biol.
24:1138–1143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Trapnell C, Williams BA, Pertea G,
Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter
L: Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
31
|
Kanehisa M, Sato Y, Furumichi M, Morishima
K and Tanabe M: New approach for understanding genome variations in
KEGG. Nucleic Acids Res. 47(D1): D590–D595. 2019. View Article : Google Scholar :
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Liu J, Mao C, Dong L, Kang P, Ding C,
Zheng T, Wang X and Xiao Y: Excessive iodine promotes pyroptosis of
thyroid follicular epithelial cells in Hashimoto's thyroiditis
through the ROS-NF-KB-NLRP3 pathway. Front Endocrinol (Lausanne).
10:7782019. View Article : Google Scholar
|
|
34
|
Kotkowska A, Sewerynek E, Domanska D,
Pastuszak-Lewandoska D and Brzezianska E: Single nucleotide
polymorphisms in the STAT3 gene influence AITD susceptibility,
thyroid autoantibody levels, and IL6 and IL17 secretion. Cell Mol
Biol Lett. 20:88–101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jankovic B, Le KT and Hershman JM:
Clinical review: Hashimoto's thyroiditis and papillary thyroid
carcinoma: Is there a correlation? J Clin Endocrinol Metab.
98:474–482. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stanilova SA, Gerenova JB, Miteva LD and
Manolova IM: The role of transforming growth factor-β1 gene
polymorphism and its serum levels in Hashimoto's thyroiditis. Curr
Pharm Biotechnol. 19:581–589. 2018. View Article : Google Scholar
|
|
37
|
Luo X, Zheng T, Mao C, Dong X, Mou X, Xu
C, Lu Q, Liu B, Wang S and Xiao Y: Aberrant MRP14 expression in
thyroid follicular cells mediates chemokine secretion through the
IL-1β/MAPK pathway in Hashimoto's thyroiditis. Endocr Connect.
7:850–858. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thomas T, Sreedharan S, Khadilkar UN,
Deviprasad D, Kamath MP, Bhojwani KM and Alva A: Clinical,
biochemical & cytomorphologic study on Hashimoto's thyroiditis.
Indian J Med Res. 140:729–735. 2014.
|
|
39
|
Dias Lopes NM, Mendonca Lens HH, Armani A,
Marinello PC and Cecchini AL: Thyroid cancer and thyroid autoimmune
disease: A review of molecular aspects and clinical outcomes.
Pathol Res Pract. 216:1530982020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Satpathy AT and Chang HY: Long noncoding
RNA in hematopoiesis and immunity. Immunity. 42:792–804. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen YG, Satpathy AT and Chang HY: Gene
regulation in the immune system by long noncoding RNAs. Nat
Immunol. 18:962–972. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ballantyne MD, McDonald RA and Baker AH:
lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol
Ther. 99:494–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fang S, Shen Y, Chen B, Wu Y, Jia L, Li Y,
Zhu Y, Yan Y, Li M, Chen R, et al: H3K27me3 induces multidrug
resistance in small cell lung cancer by affecting HOXA1 DNA
methylation via regulation of the lncRNA HOTAIR. Ann Transl Med.
6:4402018. View Article : Google Scholar :
|
|
44
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiu YY, Wu Y, Lin MJ, Bian T, Xiao YL and
Qin C: LncRNA-MEG3 functions as a competing endogenous RNA to
regulate Treg/Th17 balance in patients with asthma by targeting
microRNA-17/RORүt. Biomed Pharmacother. 111:386–394. 2019.
View Article : Google Scholar
|
|
46
|
Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S,
Jiang Z, Xu J, Liu Q and Cao X: The STAT3-binding long noncoding
RNA lnc-DC controls human dendritic cell differentiation. Science.
344:310–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nanba T, Watanabe M, Inoue N and Iwatani
Y: Increases of the Th1/Th2 cell ratio in severe Hashimoto's
disease and in the proportion of Th17 cells in intractable Graves'
disease. Thyroid. 19:495–501. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu Y, Tang X, Tian J, Zhu C, Peng H, Rui
K, Wang Y, Mao C, Ma J, Lu L, et al: Th17/Treg cells imbalance and
GITRL profile in patients with Hashimoto's thyroiditis. Int J Mol
Sci. 15:21674–21686. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zheng T, Xu C, Mao C, Mou X, Wu F, Wang X,
Bu L, Zhou Y, Luo X, Lu Q, et al: Increased interleukin-23 in
Hashimoto's thyroiditis disease induces autophagy suppression and
reactive oxygen species accumulation. Front Immunol. 9:962018.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xia N, Chen G, Liu M, Ye X, Pan Y, Ge J,
Mao Y, Wang H, Wang J and Xie S: Anti-inflammatory effects of
luteolin on experimental autoimmune thyroiditis in mice. Exp Ther
Med. 12:4049–4054. 2016. View Article : Google Scholar
|
|
51
|
Larson SD, Jackson LN, Riall TS, Uchida T,
Thomas RP, Qiu S and Evers BM: Increased incidence of
well-differentiated thyroid cancer associated with Hashimoto
thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg.
204:764–775. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhou Y, Qiu X, Luo Y, Yuan J, Li Y, Zhong
Q, Zhao M and Lu Q: Histone modifications and methyl-CpG-binding
domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T
cells. Lupus. 20:1365–1371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vecellio M, Wu H, Lu Q and Selmi C: The
multifaceted functional role of DNA methylation in immune-mediated
rheumatic diseases. Clin Rheumatol. Jul 2–2020.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Miao CG, Huang C, Huang Y, Yang YY, He X,
Zhang L, Lv XW, Jin Y and Li J: MeCP2 modulates the canonical Wnt
pathway activation by targeting SFRP4 in rheumatoid arthritis
fibroblast-like synoviocytes in rats. Cell Signal. 25:598–608.
2013. View Article : Google Scholar
|
|
55
|
Sun ZH, Liu YH, Liu JD, Xu DD, Li XF, Meng
XM, Ma TT, Huang C and Li J: MeCP2 regulates PTCH1 expression
through DNA methylation in rheumatoid arthritis. Inflammation.
40:1497–1508. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Guy J, Cheval H, Selfridge J and Bird A:
The role of MeCP2 in the brain. Annu Rev Cell Dev Biol. 27:631–652.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Miao CG, Yang YY, He X and Li J: New
advances of DNA methylation and histone modifications in rheumatoid
arthritis, with special emphasis on MeCP2. Cell Signal. 25:875–882.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chahrour M, Jung SY, Shaw C, Zhou X, Wong
ST, Qin J and Zoghbi HY: MeCP2, a key contributor to neurological
disease, activates and represses transcription. Science.
320:1224–1229. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Henderson J, Brown M, Horsburgh S, Duffy
L, Wilkinson S, Worrell J, Stratton R and O'Reilly S: Methyl cap
binding protein 2: A key epigenetic protein in systemic sclerosis.
Rheumatology (Oxford). 58:527–535. 2019. View Article : Google Scholar
|
|
60
|
Cobb BL, Fei Y, Jonsson R, Bolstad AI,
Brun JG, Rischmueller M, Lester SE, Witte T, Illei G, Brennan M, et
al: Genetic association between methyl-CpG binding protein 2
(MECP2) and primary Sjogren's syndrome. Ann Rheum Dis.
69:1731–1732. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Song RH, Qin Q, Yan N, Muhali FS, Meng S,
He ST and Zhang JA: Variants in IRAK1-MECP2 region confer
susceptibility to autoimmune thyroid diseases. Mol Cell Endocrinol.
399:244–249. 2015. View Article : Google Scholar
|
|
62
|
Nie J, Li YY, Zheng SG, Tsun A and Li B:
FOXP3(+) treg cells and gender bias in autoimmune diseases. Front
Immunol. 6:4932015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lal G, Zhang N, van der Touw W, Ding Y, Ju
W, Bottinger EP, Reid SP, Levy DE and Bromberg JS: Epigenetic
regulation of Foxp3 expression in regulatory T cells by DNA
methylation. J Immunol. 182:259–273. 2009. View Article : Google Scholar
|
|
64
|
Sopena F, Nerin JM, Prats E, Banzo J,
Ducons JA, López Zaborras J and Gomollón F: Gammagraphy with
labeled leukocytes as an activity and extension index of Crohn
disease. Rev Esp Enferm Dig. 79:387–392. 1991.In Spanish.
|
|
65
|
Li MO and Rudensky AY: T cell receptor
signalling in the control of regulatory T cell differentiation and
function. Nat Rev Immunol. 16:220–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Dominguez-Villar M and Hafler DA:
Regulatory T cells in autoimmune disease. Nat Immunol. 19:665–673.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jiang S, Li C, McRae G, Lykken E, Sevilla
J, Liu SQ, Wan Y and Li QJ: MeCP2 reinforces STAT3 signaling and
the generation of effector CD4+ T cells by promoting
miR-124-mediated suppression of SOCS5. Sci Signal. 7:ra252014.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Guan LJ, Wang X, Meng S, Shi LF, Jiang WJ,
Xiao L, Shi XH, Xu J and Zhang JA: Increased IL-21/IL-21R
expression and its proinflammatory effects in autoimmune thyroid
disease. Cytokine. 72:160–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Jia X, Zhai T and Zhang JA: Metformin
reduces autoimmune antibody levels in patients with Hashimoto's
thyroiditis: A systematic review and meta-analysis. Autoimmunity.
53:353–361. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li Y, Teng D, Shan Z, Teng X, Guan H, Yu
X, Fan C, Chong W, Yang F, Dai H, et al: Antithyroperoxidase and
antithyroglobulin antibodies in a five-year follow-up survey of
populations with different iodine intakes. J Clin Endocrinol Metab.
93:1751–1757. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Dong YH and Fu DG: Autoimmune thyroid
disease: Mechanism, genetics and current knowledge. Eur Rev Med
Pharmacol Sci. 18:3611–3618. 2014.PubMed/NCBI
|
|
72
|
Yan YR, Gao XL, Zeng J, Liu Y, Lv QG,
Jiang J, Huang H and Tong NW: The association between thyroid
autoantibodies in serum and abnormal function and structure of the
thyroid. J Int Med Res. 43:412–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
